Skip to main content
SpringerLink
Log in

Therapeutische Erreichbarkeit der Retina bei systemischen immunmodulatorischen Ansätzen bei Mausmodellen für neuronale Ceroid-Lipofuszinosen

Kommentar zu Bartsch et al., Der Ophthalmologe, 02/2021

Therapeutic accessibility of the retina in systemic immunomodulatory approaches in mouse models for neuronal ceroid lipofuscinosis

Comments on Bartsch et al., Der Ophthalmologe 02/2021

  • Leserbriefe
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

A Leserbriefe to this article was published on 04 June 2021

The Original Article was published on 08 October 2020

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bartsch S, Liu J, Bassal M et al (2021) Experimental therapeutic approaches for the treatment of retinal dystrophy in neuronal ceroid lipofuscinosis. Ophthalmologe 118:106–112

    Article  Google Scholar 

  2. Behnke V, Langmann T (2021) Neuroinflammation in neuronal ceroid lipofuscinosis. Ophthalmologe 118:98–105

    Article  CAS  Google Scholar 

  3. Dannhausen K, Mohle C, Langmann T (2018) Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage. Dis Model Mech. https://doi.org/10.1242/dmm.033597

    Article  PubMed  PubMed Central  Google Scholar 

  4. Groh J, Berve K, Martini R (2017) Fingolimod and teriflunomide attenuate neurodegeneration in mouse models of neuronal ceroid lipofuscinosis. Mol Ther 25:1889–1899

    Article  CAS  Google Scholar 

  5. Groh J, Berve K, Martini R (2021) Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onset. Brain Commun. https://doi.org/10.1093/braincomms/fcab047

    Article  PubMed  PubMed Central  Google Scholar 

  6. Groh J, Kuhl TG, Ip CW et al (2013) Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis. Brain 136:1083–1101

    Article  Google Scholar 

  7. Kielar C, Maddox L, Bible E et al (2007) Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 25:150–162

    Article  CAS  Google Scholar 

  8. Mirza M, Volz C, Karlstetter M et al (2013) Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation. PLOS ONE 8:e75963

    Article  CAS  Google Scholar 

  9. Pontikis CC, Cella CV, Parihar N et al (2004) Late onset neurodegeneration in the Cln3-/-mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Brain Res 1023:231–242

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimentelle Entwicklungsneurobiologie, Neurologische Klinik, Universitätsklinikum Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Deutschland

    Rudolf Martini & Janos Groh

  2. Augenklinik, Universitätsklinikum Bonn, Bonn, 53127, Deutschland

    Thomas Ach

  3. Zentrum für Neuropädiatrie, Entwicklungsneurologie und Sozialpädiatrie, Vestische Kinder- und Jugendklinik Datteln, Datteln, 45711, Deutschland

    Kevin Rostasy

Authors
  1. Rudolf Martini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Ach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin Rostasy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Janos Groh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rudolf Martini.

Ethics declarations

Interessenkonflikt

R. Martini gibt an, dass einige der erwähnten präklinischen Studien aus seinem Labor von Sanofi Genzyme USA unterstützt wurden. K. Rostasi gibt unbezahlte Beratertätigkeit für Novartis an. T. Ach und J. Groh geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martini, R., Ach, T., Rostasy, K. et al. Therapeutische Erreichbarkeit der Retina bei systemischen immunmodulatorischen Ansätzen bei Mausmodellen für neuronale Ceroid-Lipofuszinosen. Ophthalmologe 118, 767–768 (2021). https://doi.org/10.1007/s00347-021-01418-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-021-01418-0

Search

Navigation